Atlas Trials

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT00225212 · COMPLETED

Trial details

NCT number
NCT00225212
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell LymphomaTransformed LymphomaOther Subtypes of B-cell LymphomaLymphoma
Start date
1997-11-01
Primary completion
2003-03-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.